Umbelliferone

Synonyms: 7-羟基香豆素; 7-Hydroxycoumarin; Hydrangin; NSC 19790
Umbelliferone (7-Hydroxycoumarin) 是香豆素家族的天然产物,具有口服活性,是一种可用作防晒剂的荧光化合物,可诱导 HepG2 细胞的细胞周期停滞、凋亡 (apoptosis) 和 DNA 片段化,具有显著的抗癌作用,能减轻过敏性气道炎症的改变特征,显示出神经保护作用并穿过血脑屏障,且在慢性酒精喂养的大鼠中表现出抗炎和抗氧化作用。
产品编号: MS-C61671 纯度: 99.67% CAS No.: 93-35-6 分子式: C9H6O3 分子量: 162.14
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
5g
询价
3-5 天
10g
询价
3-5 天
25g
询价
3-5 天
50g
询价
3-5 天
100g
询价
3-5 天
250g
询价
3-5 天
500g
询价
3-5 天
> 100g
询价
询价

产品描述

Umbelliferone (7-Hydroxycoumarin) 是香豆素家族的天然产物,具有口服活性,是一种可用作防晒剂的荧光化合物,可诱导 HepG2 细胞的细胞周期停滞、凋亡 (apoptosis) 和 DNA 片段化,具有显著的抗癌作用,能减轻过敏性气道炎症的改变特征,显示出神经保护作用并穿过血脑屏障,且在慢性酒精喂养的大鼠中表现出抗炎和抗氧化作用。

生物实验数据

生物活性 Umbelliferone (7-Hydroxycoumarin) is a natural product of the coumarin family that is orally active and is a fluorescent compound usable as a sunscreen agent; it induces cell cycle arrest, apoptosis, and DNA fragmentation in HepG2 cells, exhibits significant anticancer effects, alleviates the altered features of allergic airway inflammation, shows neuroprotective effects and crosses the blood-brain barrier, and displays anti-inflammatory and antioxidant effects in chronically alcohol-fed rats.
IC50 & Target

Human Endogenous Metabolite

 

体外研究
(In Vitro)

Umbelliferone (1-50 μM, 12-48 h) 诱导 HepG2 细胞活力降低并呈现剂量和时间依赖性。
Umbelliferone (0-50 μM, 24 h) 导致 HepG2 细胞收缩,膜起泡,核浓缩和凋亡小体形成。

Apoptosis Analysis

Cell Line: HepG2 cells
Concentration: 0, 5, 25 50 μM
Incubation Time: 24 h
Result: Resulted in the appearance of cell shrinkage and membrane blebbing, when compared with the morphology of untreated cells.
At 50 μM almost all the HepG2 cancer cells shrank significantly and no cells with normal morphological features were detected.
Reduced large nuclei.
Induced nuclear condensation and apoptotic body formation.

Cell Cycle Analysis

Cell Line: HepG2 cells
Concentration: 0, 5, 25 50 μM
Incubation Time: 24 h
Result: Increased in the proportion of cells in S phase (45.0, 51.3 and 62.1%, compared with 43.6% in untreated cells) and reduced in the fraction of cells in G1 phase (42.1, 45.6 and 32.2%, compared with 53.2% in the untreated cells).
体内研究
(In Vivo)

Umbelliferone (90 mg/kg, p.o., 每日, 5 天) 可减少受攻击小鼠支气管肺泡灌洗液中的总细胞,中性粒细胞,嗜酸性粒细胞和单核细胞的数量。
Umbelliferone (15-30mg/kg, i.g., 每日, 21 天) 对 CUMS (慢性不可预测的轻度应激) 诱导的抑郁症鼠模型显示出神经保护作用,这与抑制 ROCK/Akt 通路调节的神经元凋亡有关。
Umbelliferone (0.05 g/L, 口服, 每日, 8 周) 通过抑制 TLR4 信号通路和激活抗氧化系统来预防用含 5% 酒精的利伯德卡里流质饮食诱导大鼠的肝损伤。

Animal Model: Male BALB/c mice, 4-6 weeks old received systemic immunization by subcutaneous injection of 10 μg of chicken egg ovalbumin diluted in 2 mg/mL alum followed by a booster injection at day 14. A nasal challenge was performed starting at day 28, by inhalational exposure to aerosolised ovalbumin for 15 min/day, on five consecutive days.
Dosage: 30, 60, 90 mg/kg
Administration: p.o., daily, 5 days
Result: Mice sensitized and challenged with ovalbumin have increased the number of inflammatory cells in bronchoalveolar lavage fluid.
Reduced the number of total cells and of neutrophils in the bronchoalveolar lavage fluid.
At 60 and 90 mg/kg, but not at 30 mg/kg, decreased significantly the number of eosinophils found in the bronchoalveolar lavage fluid of challenged mice.
At 60 mg/kg, decreased the number of mononuclear cells.
Caused a reduction in the levels of Th2-associated cytokines (IL-4, IL-5, IL-13).
Animal Model: While the control group of rats without receiving stress treatment had free access to food and water, other groups of rats were subjected to different types of stressors: cage tilting for 24 h, damp sawdust for 24 h, predator sounds, swimming in 4 ℃ cold water for 5min, swimming in 45 ℃ hot water for 5min, fasting for 48 h, water deprivation for 24 h, shaking for 15 min, nip trail for 1 min.
Dosage: 15,30 mg/kg
Administration: i.g., daily, 21 days
Result: Exhibited an antidepressant-like effect, as sucrose consumption in CUMS rats significantly increased.
Decreased the expression of caspase3 and bax and increased the expression of bcl2 in CA1 region of hippocampus compared to the control group.
Remarkably increased the number of nissl-positive cells.
Down-regulated the levels of inflammatory cytokines IL-1β, IL-6 and TNF-α in hippocampus in the CUMS group versus control group.
Decreased the protein level of ROCK2 and phosphorylation expression of PTEN stimulated by CUMS.
Up-regulated the phosphorylation expressions of Akt and GSK3.
Animal Model: Rats were fed a Liber-Decarli liquid diet containing 5% alcohol for 8 weeks, while normal rats received an isocaloric carbohydrate liquid diet.
Dosage: 0.05 g/L
Administration: p.o., daily, 8 weeks
Result: Decreased in serum TNF-α and IL-6 levels and increased IL-10 level.
Decreased the mRNA expressions of LBP, TLR4, NF-κB and TNF-α and IL-6.
Up-regulated SOD and CAT mRNA levels and activity.
Increased H2O2 and GSH levels and decreased hepatic MDA (Malondialdehyde) levels.
性状 固体

化学信息

分子量 162.14
分子式 C9H6O3
CAS No. 93-35-6
别名 7-羟基香豆素; 7-Hydroxycoumarin; Hydrangin; NSC 19790

储存&溶解度

体内实验配方
10% DMSO+90% Saline: < 10 mg/mL (61.68 mM), Lower concentrations may be soluble, but exact solubility limit is unknown.
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 10.00 mg/mL (61.67 mM), Solution.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 100 mg/mL (616.75 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

H2O 中的溶解度 : < 0.1 mg/mL (insoluble)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM6.1675 mL30.8375 mL61.6751 mL154.1877 mL
5 mM1.2335 mL6.1675 mL12.3350 mL30.8375 mL
10 mM0.6168 mL3.0838 mL6.1675 mL15.4188 mL
15 mM0.4112 mL2.0558 mL4.1117 mL10.2792 mL
20 mM0.3084 mL1.5419 mL3.0838 mL7.7094 mL
25 mM0.2467 mL1.2335 mL2.4670 mL6.1675 mL
30 mM0.2056 mL1.0279 mL2.0558 mL5.1396 mL
40 mM0.1542 mL0.7709 mL1.5419 mL3.8547 mL
50 mM0.1234 mL0.6168 mL1.2335 mL3.0838 mL
60 mM0.1028 mL0.5140 mL1.0279 mL2.5698 mL
80 mM0.0771 mL0.3855 mL0.7709 mL1.9273 mL
100 mM0.0617 mL0.3084 mL0.6168 mL1.5419 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础